Home › Leukemia › Ohio › Akron
Leukemia clinical trials in Akron, OH
4 studies for Leukemia are looking for participants at sites in and around Akron (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Integrated Cancer Repository for Cancer Research
RecruitingObservational studyHealthy volunteers welcome
- Aultman Hospital, Canton · 21 mi away
- Aultman Alliance Community Hospital, Alliance · 24 mi away
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
RecruitingObservational study
- Children's Hospital Medical Center of Akron, Akron
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
RecruitingPhase 1/2
- Gabrail Cancer Center Research,, Canton · 21 mi away
Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia
RecruitingPhase 1
- Gabrail Cancer Research Center, Canton · 21 mi away
About Leukemia
Leukemia is cancer of the white blood cells. There are two types of Leukemias, acute and chronic. Learn about the differences and treatments available.
More about Leukemia on MedlinePlus
Leukemia trials in other cities
- Houston, TX28 studies
- Boston, MA25 studies
- New York City, NY19 studies
- Los Angeles, CA16 studies
- Chicago, IL16 studies
- Durham, NC13 studies
- Baldwin Park, CA12 studies
- Nashville, TN12 studies
- Columbus, OH12 studies
- Philadelphia, PA12 studies
- Milwaukee, WI11 studies
- Atlanta, GA11 studies
Other studies in Akron
- Non-Small Cell Lung Cancer22 studies
- Lung Cancer16 studies
- Cancer (all types)13 studies
- Breast Cancer13 studies
- Prostate Cancer9 studies
- Acute Myeloid Leukemia8 studies
- Melanoma8 studies
- Small Cell Lung Cancer8 studies
- Metastatic Cancer8 studies
- Colorectal Cancer8 studies
- Steatotic Liver Disease7 studies
- Endometrial Cancer6 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.